SCHEMBL13065602

SCHEMBL13065602

CCN(CC)c1ccc2nc3c(C(=O)O)c(-c4ccc(OC)cc4)c(=O)c(OC)c-3oc2c1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SCP2 P22307 1/20 0.44
MEN1 O00255 3/20 0.42
KMT2A Q03164 3/20 0.42
MAPT P10636 3/20 0.42
LMNA P02545 2/20 0.42
MAPK1 P28482 2/20 0.42
USP2 O75604 1/20 0.42
HTT P42858 1/20 0.42
ATM Q13315 1/20 0.42
TDP1 Q9NUW8 1/20 0.42
L3MBTL1 Q9Y468 1/20 0.42
GPR84 Q9NQS5 7/20 0.42
NPC1 O15118 1/20 0.41
POLB P06746 1/20 0.41
RAB9A P51151 1/20 0.41
ALDH1A1 P00352 3/20 0.40
SMN1; SMN2 Q16637 2/20 0.40
NPSR1 Q6W5P4 1/20 0.40
KDM4E B2RXH2 2/20 0.39
SLC16A3 O15427 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13065604 0.93 MEN1 (0.41) SCP2MEN1KMT2AMAPTLMNA
SCHEMBL13065593 0.93 MEN1 (0.41) SCP2MEN1KMT2AMAPTLMNA
SCHEMBL13065624 0.93 DHODH (0.42) SCP2MEN1KMT2AMAPTLMNA
SCHEMBL13065600 0.93 MEN1 (0.47) SCP2MEN1KMT2AMAPTLMNA
SCHEMBL13065588 0.92 MEN1 (0.41) SCP2MEN1KMT2AMAPTLMNA
SCHEMBL13065586 0.91 SCP2 (0.44) SCP2MEN1KMT2AMAPTLMNA
SCHEMBL13065613 0.91 MEN1 (0.42) SCP2MEN1KMT2AMAPTLMNA
SCHEMBL13065606 0.91 SCP2 (0.41) SCP2MEN1KMT2AMAPTLMNA
SCHEMBL16784718 0.90 MAPT (0.41) MEN1KMT2AMAPTHTTTDP1
SCHEMBL13065608 0.90 MEN1 (0.39) SCP2MEN1KMT2AMAPTLMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9052324-B2 Compounds and assays for controlling Wnt activity ENZO BIOCHEM, INC. (US) 2015-06-09 US disclosed
US-20120322717-A9 Compounds and assays for controlling Wnt activity ENZO BIOCHEM, INC. 2012-12-20 US disclosed
US-20100298200-A1 Compounds and assays for controlling Wnt activity LIU DAKAI 2010-11-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120322717-A9 Compounds and assays for controlling Wnt activity WNT1, WNT3A, WNT3 SCP2 2220/4885MEN1 3364/4885KMT2A 4381/4885
US-20100298200-A1 Compounds and assays for controlling Wnt activity WNT1, WNT3A, WNT3 SCP2 2220/4885MEN1 3364/4885KMT2A 4381/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.